Literature DB >> 16133943

Cyclosporin A aggravates electroshock-induced convulsions in mice with a transient middle cerebral artery occlusion.

Atsushi Yamauchi1, Hideki Shuto, Shinya Dohgu, Yoshitsugu Nakano, Takashi Egawa, Yasufumi Kataoka.   

Abstract

1. To test whether an ischemic insult increases the susceptibility to cyclosporine A (CsA)-induced neurotoxicity, we examined the effect of CsA on the minimal electroshock-induced convulsions in mice treated with a transient middle cerebral artery occlusion (MCAO) for a short period (2 h). 2. This MCAO produced small to mid-sized infarcted regions in the cerebral hemisphere with increasing post-operative days. In MCAO mice, CsA (30 mg/kg, i.p.) elevated the incidence of minimal electroshock-induced convulsions to 90-100% over that in sham mice (20-30%) at 1-7 days but not 14 days post-surgery. 3. In light of these findings, the possibility that CsA increases the risk of convulsions in patients with cerebral infarction and/or at an early stage following focal cerebral ischemia would have to be considered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133943     DOI: 10.1007/s10571-005-4956-5

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  14 in total

1.  Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia.

Authors:  T Yoshimoto; B K Siesjö
Journal:  Brain Res       Date:  1999-08-28       Impact factor: 3.252

2.  Cyclosporine A-increased nitric oxide production in the rat dorsal hippocampus mediates convulsions.

Authors:  Yuko Fujisaki; Atsushi Yamauchi; Shinya Dohgu; Kazuyuki Sunada; Chozaburou Yamaguchi; Ryozo Oishi; Yasufumi Kataoka
Journal:  Life Sci       Date:  2002-12-20       Impact factor: 5.037

3.  Transcellular transport as a mechanism of blood-brain barrier disruption during stroke.

Authors:  Marilyn J Cipolla; Ryan Crete; Lisa Vitullo; Robert D Rix
Journal:  Front Biosci       Date:  2004-01-01

Review 4.  Cyclosporine neurotoxicity: a review.

Authors:  J M Gijtenbeek; M J van den Bent; C J Vecht
Journal:  J Neurol       Date:  1999-05       Impact factor: 4.849

5.  Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells.

Authors:  S Kochi; H Takanaga; H Matsuo; M Naito; T Tsuruo; Y Sawada
Journal:  Eur J Pharmacol       Date:  1999-05-21       Impact factor: 4.432

6.  Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.

Authors:  S G Sydserff; A R Borelli; A R Green; A J Cross
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

7.  Impairment and restoration of the endothelial blood-brain barrier in the rat cerebral infarction model assessed by expression of endothelial barrier antigen immunoreactivity.

Authors:  K Nishigaya; S Yagi; T Sato; K Kanemaru; H Nukui
Journal:  Acta Neuropathol       Date:  2000-03       Impact factor: 17.088

8.  The immunosuppressants cyclosporin A and FK506 equally ameliorate brain damage due to 30-min middle cerebral artery occlusion in hyperglycemic rats.

Authors:  S Kuroda; S Janelidze; B K Siesjö
Journal:  Brain Res       Date:  1999-07-24       Impact factor: 3.252

9.  Neuroprotective properties of lifarizine compared with those of other agents in a mouse model of focal cerebral ischaemia.

Authors:  C M Brown; C Calder; C Linton; C Small; B A Kenny; M Spedding; L Patmore
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

10.  Vitamin E isoforms alpha-tocotrienol and gamma-tocopherol prevent cerebral infarction in mice.

Authors:  Kenichi Mishima; Takamitsu Tanaka; Fengling Pu; Nobuaki Egashira; Katsunori Iwasaki; Ryoji Hidaka; Kazuhisa Matsunaga; Jiro Takata; Yoshiharu Karube; Michihiro Fujiwara
Journal:  Neurosci Lett       Date:  2003-01-30       Impact factor: 3.046

View more
  4 in total

1.  Therapeutic benefit of treatment of stroke with simvastatin and human umbilical cord blood cells: neurogenesis, synaptic plasticity, and axon growth.

Authors:  Xu Cui; Michael Chopp; Amjad Shehadah; Alex Zacharek; Nicole Kuzmin-Nichols; Cyndy Davis Sanberg; Junhao Dai; Chunling Zhang; Yuji Ueno; Cynthia Roberts; Jieli Chen
Journal:  Cell Transplant       Date:  2012-03-08       Impact factor: 4.064

2.  RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).

Authors:  Shimin Liu; Gehua Zhen; Bruno P Meloni; Kym Campbell; H Richard Winn
Journal:  J Exp Stroke Transl Med       Date:  2009-01-01

3.  Transplantation of cryopreserved human umbilical cord blood mononuclear cells does not induce sustained recovery after experimental stroke in spontaneously hypertensive rats.

Authors:  Gesa Weise; Marlene Lorenz; Claudia Pösel; Ute Maria Riegelsberger; Veronika Störbeck; Manja Kamprad; Alexander Kranz; Daniel-Christoph Wagner; Johannes Boltze
Journal:  J Cereb Blood Flow Metab       Date:  2013-10-30       Impact factor: 6.200

4.  Adverse effect of cyclosporin A on barrier functions of cerebral microvascular endothelial cells after hypoxia-reoxygenation damage in vitro.

Authors:  Shinya Dohgu; Tsuyoshi Nishioku; Noriko Sumi; Fuyuko Takata; Shinsuke Nakagawa; Mikihiko Naito; Takashi Tsuruo; Atsushi Yamauchi; Hideki Shuto; Yasufumi Kataoka
Journal:  Cell Mol Neurobiol       Date:  2007-10-13       Impact factor: 5.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.